Home
overview
A unique opportunity to learn from leading industry experts including:

Dr Thomas Eichholtz, GlaxoSmithKline
Dr Philip Barr, Chief Operating Officer, Arriva Pharmaceuticals
Dr Anthony Sandrasagra, Vice President, EpiGenesis Pharmaceuticals
Dr Gwynneth Clay, Project Manager, PPL Therapeutics
Dr Mark Parry Billings, Director, Research & Development, Innovata Biomed
Dr John Staniforth, Chief Scientific Officer, Vectura Drug Delivery
Dr Carmen Skurdal, Clinical Director, Cardiopulmonary programmes, Gentiva Health Services
Dr Johannes Christof Stein, International Business Development Manager, PARI Aerosol Research Institute
Laurie DiModica, Senior Analyst, Decision Resources
Dr Susan Lawlor, Senior Analyst Datamonitor Healthcare, Datamonitor

Conference programme

8:30 Registration & Coffee

9:00 Chairman's Opening Remarks

Dr Anthony Sandrasagra

Dr Anthony Sandrasagra, Vice President, EpiGenesis Pharmaceuticals

9:10 STRATEGIC OVERVIEW OF THE COPD MARKET

Dr Susan Lawlor

Dr Susan Lawlor, Senior Analyst, Datamonitor Healthcare, Datamonitor

  • The global COPD market
  • Patient education and compliance
  • Types of medications in use, analysis
  • Meeting the unmet needs of COPD treatment
  • Market forecasts
  • 9:40 EXISTING AND NEW DRUGS FOR COPD

    Laurie DeModica

    Laurie DeModica, Senior Analyst, Decision Resources

  • COPD Treatment Overview: The Main Goals of Available COPD Therapies
  • Existing Products (b-agonists, Inhaled corticosteroids, Anticholinergics, Methylxanthine Derivatives, Leukotriene Antagonists, Smoking Cessation Products, Others)
  • Combination Therapies
  • Clinical Trials for Respiratory Drugs
  • Current Status of the COPD Drugs Market: Where are the Opportunities for Development?
  • How Close is the Breakthrough?
  • 10:20 SELECTING AN EFFECTIVE DELIVERY TECHNOLOGY

    Dr Mark Parry Billings

    Dr Mark Parry Billings, Director, Research and Development, Innovata Biomed

  • Overview of delivery options and recent advances
  • Selection of the optimal technology
  • Key challenges in development and registration
  • Future perspectives
  • 11:00 Morning Coffee

    11:20 ADVANCES IN PULMONARY DELIVERY TECHNOLOGY

    Professor John Staniforth

    Professor John Staniforth, Chief Scientific Officer, Vectura Drug Delivery

  • Factors affecting successful delivery systems
  • Approaches to achieving site specific delivery
  • Application of novel formulation technology to a product development programme for COPD
  • 12:00 LIQUID INHALATION IN PULMONARY DELIVERY TECHNOLOGY

    Dr Johannes Christof Stein

    Dr Johannes Christof Stein, International Business Development Manager, PARI Aerosol Research Institute

  • Key points of therapy with respect to the special needs of COPD patients
  • Understanding patient use and misuse of inhalation devices
  • Approaches to overcome unwanted side effects
  • Factors for successful delivery devices
  • New devices: results
  • 12:40 Lunch

    13:40 NEW TARGETS FOR COPD TREATMENT

    Dr Philip Barr

    Dr Philip Barr, Chief Scientific Officer, Arriva

  • Development of early-onset emphysema
  • Progressive development of emphysematous changes in the peripheral airways
  • MMP inhibitors
  • Treatment of AAT deficiency
  • Bifunctional protease inhibitors

    Studies of airway secretions

  • The role of other enzymes in COPD

    Viable targets for therapy in the long term

  • 14:20 GENE THERAPY

    Dr Thomas Eichholtz

    Dr Thomas Eichholtz, , GlaxoSmithKline

  • Overview
  • Known endogenous and exogenous risk factors in COPD
  • Role of genetic factors in COPD
  • Methods to discover novel susceptibility genes for COPD
  • 15:00 HEREDITARY COPD

    Dr Gwynneth Clay

    Dr Gwynneth Clay, Project Manager, PPL Therapeutics

  • Proteases as key components of the host immune response
  • Mechanisms to counteract activity of proteases, protease-protease inhibitor balance
  • Critical role of proteases in emphysema
  • Chronic inflammatory response in smoking-related emphysema
  • AAT levels depending on genetic variants (M,S and Z)
  • Recombinant versions of AAT (Prolastin)
  • 15:40 Afternoon Tea

    16:00 RASON TECHNOLOGY: SIMULTANEOUS IN VIVO TARGET VALIDATION AND ANTISENSE THERAPEUTIC DISCOVERY IN THE RESPIRATORY TRACT

    Dr Anthony Sandrasagra

    Dr Anthony Sandrasagra, Vice President, EpiGenesis Pharmaceuticals

    16:30 SUCCESSFUL DELIVERY OF COMPLEX INFUSION THERAPY IN THE HOME

    Carmen Skurdal

    Carmen Skurdal, National Clinical Director, Cardiopulmonary Programs, Gentiva Health Services

  • From Clinical trials to Launch
  • Building clinical support services for physicians and patients
  • Clinical care management at home using the “Team” approach
  • Emerging USA health and payment policies that can impact on marketing and distribution
  • 17:00 Chairman's Closing Remarks and Close of Conference

    +

    Workshops

    COPD Market Mapping
    Workshop

    COPD Market Mapping

    The Hatton, at etc. venues
    22nd November 2001
    London, United Kingdom

    The Hatton, at etc. venues

    51/53 Hatton Garden
    London EC1N 8HN
    United Kingdom

    The Hatton, at etc. venues

    HOTEL BOOKING FORM

    Title

    SubTitle
    speaker image

    Content


    Title


    Description

    Download


    WHAT IS CPD?

    CPD stands for Continuing Professional Development’. It is essentially a philosophy, which maintains that in order to be effective, learning should be organised and structured. The most common definition is:

    ‘A commitment to structured skills and knowledge enhancement for Personal or Professional competence’

    CPD is a common requirement of individual membership with professional bodies and Institutes. Increasingly, employers also expect their staff to undertake regular CPD activities.

    Undertaken over a period of time, CPD ensures that educational qualifications do not become obsolete, and allows for best practice and professional standards to be upheld.

    CPD can be undertaken through a variety of learning activities including instructor led training courses, seminars and conferences, e:learning modules or structured reading.

    CPD AND PROFESSIONAL INSTITUTES

    There are approximately 470 institutes in the UK across all industry sectors, with a collective membership of circa 4 million professionals, and they all expect their members to undertake CPD.

    For some institutes undertaking CPD is mandatory e.g. accountancy and law, and linked to a licence to practice, for others it’s obligatory. By ensuring that their members undertake CPD, the professional bodies seek to ensure that professional standards, legislative awareness and ethical practices are maintained.

    CPD Schemes often run over the period of a year and the institutes generally provide online tools for their members to record and reflect on their CPD activities.

    TYPICAL CPD SCHEMES AND RECORDING OF CPD (CPD points and hours)

    Professional bodies and Institutes CPD schemes are either structured as ‘Input’ or ‘Output’ based.

    ‘Input’ based schemes list a precise number of CPD hours that individuals must achieve within a given time period. These schemes can also use different ‘currencies’ such as points, merits, units or credits, where an individual must accumulate the number required. These currencies are usually based on time i.e. 1 CPD point = 1 hour of learning.

    ‘Output’ based schemes are learner centred. They require individuals to set learning goals that align to professional competencies, or personal development objectives. These schemes also list different ways to achieve the learning goals e.g. training courses, seminars or e:learning, which enables an individual to complete their CPD through their preferred mode of learning.

    The majority of Input and Output based schemes actively encourage individuals to seek appropriate CPD activities independently.

    As a formal provider of CPD certified activities, SMI Group can provide an indication of the learning benefit gained and the typical completion. However, it is ultimately the responsibility of the delegate to evaluate their learning, and record it correctly in line with their professional body’s or employers requirements.

    GLOBAL CPD

    Increasingly, international and emerging markets are ‘professionalising’ their workforces and looking to the UK to benchmark educational standards. The undertaking of CPD is now increasingly expected of any individual employed within today’s global marketplace.

    CPD Certificates

    We can provide a certificate for all our accredited events. To request a CPD certificate for a conference , workshop, master classes you have attended please email events@smi-online.co.uk

    Event Title

    Headline

    Text
    Read More

    I would like to speak at an event

    I would like to attend an event

    I would like to sponsor/exhibit at an event

    SIGN UP OR LOGIN

    Sign up
    Forgotten Password?

    Contact SMi GROUP LTD

    UK Office
    Opening Hours: 9.00 - 17.30 (local time)
    SMi Group Ltd, 1 Westminster Bridge Road, London, SE1 7XW, United Kingdom
    Tel: +44 (0) 20 7827 6000 Fax: +44 (0) 20 7827 6001
    Website: http://www.smi-online.co.uk Email: events@smi-online.co.uk
    Registered in England No: 3779287 VAT No: GB 976 2951 71




    Forgotten Password

    Please enter the email address you registered with. We will email you a new password.